Literature DB >> 6994265

Single-step selection of mouse FM3A cell mutants defective in thymidylate synthetase.

D Ayusawa, H Koyama, K Iwata, T Seno.   

Abstract

A tritium-suicide method for isolating thymidine auxotrophic mutants is described. Mutagenized mouse FM3A cells were cultured in medium containing [3H] deoxyuridine. Most of the surviving clones examined showed a phenotype of absolute thymidine auxotrophy. This phenotype is very stable and was found to be genetically recessive in cell-cell hybridization experiments. The growth of these variant clones was not supported by various pyrimidine nucleosides other than thymidine. The activity of thymidylate synthetase in crude extracts of these clones was less than 1% of that of FM3A cells. These results strongly indicate that the thymidine auxotrophic phenotype resulted from a genetic defect in thymidylate synthetase.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994265     DOI: 10.1007/bf01538800

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  5 in total

1.  Temperature-sensitive DNA mutant of Chinese hamster ovary cells with a thermolabile ribonucleotide reductase activity.

Authors:  B E Wojcik; J J Dermody; H L Ozer; B Mun; C K Mathews
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency.

Authors:  P J Houghton; G S Germain; B J Hazelton; J W Pennington; J A Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replication.

Authors:  J Neyts; G Andrei; R Snoeck; G Jähne; I Winkler; M Helsberg; J Balzarini; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

4.  Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA.

Authors:  J Balzarini; E De Clercq; D Ayusawa; T Seno
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

5.  Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine.

Authors:  Johan Vande Voorde; Suna Sabuncuoğlu; Sam Noppen; Anders Hofer; Farahnaz Ranjbarian; Steffen Fieuws; Jan Balzarini; Sandra Liekens
Journal:  J Biol Chem       Date:  2014-03-25       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.